Although SSc-IgG-induced signaling was not blocked with PDGFR kinase inhibitors or an AT1R antagonist, it is conceivable that the EGFR signaling that we observed is one part of a multi-receptor signaling system that may include PDGFR (Fig. 5). This evidence concerns the gene PDGFRB and systemic sclerosis.